– ‘4S’ SEASUNBIO SMART SHIELD SYSTEM has been launched in SNU campus as the first mobile COVID-19 diagnostic center in[…]
Read more
Category: Biomedical
Smiths Medical and Ivenix Partner to Revolutionize Infusion Management with First-Ever Comprehensive Suite of Infusion Solutions in US Healthcare Market
Bolstered by strategic investment from Smiths Medical, commercial partnership will offer best-in-class infusion systems designed to improve patient safety, advance[…]
Read more
RubrYc Therapeutics Announces a Research Collaboration and License Option Agreement With Zai Labs
SAN CARLOS, Calif.–(BUSINESS WIRE)–Apr. 14, 2021 RubrYc Therapeutics, Inc., a pre-clinical biotherapeutics company developing epitope selective therapies, today announced that[…]
Read more
LintonPharm Announces Authorization from China Health Authority (NMPA) to Proceed with a Phase 1/2 Trial Evaluating Catumaxomab for the treatment of Non-Muscle Invasive Bladder Cancer
GUANGZHOU, China–(BUSINESS WIRE)–Apr. 13, 2021 LintonPharm Co., Ltd., a China-based clinical stage biopharmaceutical company focused on the development of T[…]
Read more
GLIDE Launches Inaugural Awards for Disease Elimination
– New Abu Dhabi-based global health Institute launches its first disease elimination awards – 5 awards of up to USD200,000[…]
Read more
Takeda Begins Regulatory Submissions for Dengue Vaccine Candidate in EU and Dengue-Endemic Countries
European Medicines Agency to Conduct First-Ever Parallel Assessment of a Medicinal Product, Takeda’s Dengue Vaccine Candidate (TAK-003), for use in[…]
Read more
Premas Biotech and Oramed Announce Oral COVID-19 Vaccine Candidate That Produces Antibodies After a Single Dose
Far reaching implications for ease of widescale distribution and administration anytime, anywhere Better candidate for protection against COVID-19 variants due[…]
Read more
NTHU Research Team Develops Groundbreaking Influenza Vaccine
HSINCHU, Taiwan–(BUSINESS WIRE)–Mar. 13, 2021 Winter is the beginning of the annual influenza season, and every year, in its efforts[…]
Read more
Illuminating the Heroes of Rare Diseases
Australian health advocates join global movement to raise awareness for Rare Disease Day – Sunday 28 February SYDNEY–(BUSINESS WIRE)–Feb. 26,[…]
Read moreAptorum Group Announces Submission of Clinical Trial Application for ALS-4 an Orally Administered Small Molecule Drug for the Treatment of Infections caused by Staphylococcus aureus including Methicillin-resistant Staphylococcus aureus (MRSA)
NEW YORK & LONDON & PARIS–(BUSINESS WIRE)–Dec. 21, 2020 Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum[…]
Read more